Our portfolio spans a range of methodologies and types of research. Some of our studies are highlighted below.
|COBra||Patient reported core outcomes in brain tumour trials||Chief-Investigator: Anthony Byrne||Ongoing|
|BeCOVID||The grief experiences and support needs of people bereaved during the COVID-19 pandemic||Chief Investigator:|
Emily Harrop; Lucy Selman
|PhAB||Barriers to and facilitators of physical activity in cancer patients with brain tumours in Wales and Bangladesh||Chief Investigator: Ishrat Islam||Ongoing|
|Chronos||Comparative health research outcomes of novel surgery in prostate cancer: A phase II randomised controlled trial incorporating an internal pilot||Co-Investigators: Mirella Longo, Annmarie Nelson||Ongoing|
|Rambo||Research assessment outcome measures for malignant bowel obstruction||Chief Investigator: Simon Noble||Ongoing|
|Cochrane Review||Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers: a Cochrane Review||Chief Investigator: Anthony Byrne||Ongoing|
|Marie Curie Studentship||Developing a screening tool for the effects of radiation therapy for brain cancer||PhD Student: Francesca Mazzaschi||Ongoing|
|Girasol||Development of guidelines for the communication of research results to patients, members of the public and other stakeholder groups||Chief Investigator: Mirella Longo||Ongoing|
|Empower||Evaluating a patient designed tool to reduce harm from cancer associated thrombosis (CAT)||Chief Investigator: Simon Noble||Reporting stage|
|Bereavement Support Services||A scoping survey of bereavement support services in Wales||Chief Investigators: Anthony Byrne, Emily Harrop||Reported|
|7 Day Evaluation||An evaluation of the Cardiff and Vale University Healthboard weekend and bank holiday specialist palliative care clinical nurse specialist service||Chief Investigator: Alisha Newman||Reported|
|ROCS||Palliative radiotherapy in addition to self expanding metal stent for improving outcomes of dysphagia and survival in advanced oesophageal cancer||Co-Chief Investigator: Anthony Byrne|
We can provide free advice and support to academics, clinicians and other health professionals.